Specifics of diabetes mellitus in women

Česká verzia

Authors: Ludmila Brunerová ¹; Jan Brož ²
Authors place of work: Diabetologické centrum II. interní kliniky 3. LF UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Michal Anděl, CSc. ¹; Diabetologické centrum Interní kliniky 2. LF UK a FN Motol Praha, přednosta prof. MUDr. Milan Kvapil, CSc., MBA ²
Published in the journal: Vnitř Lék 2014; 60(7-8): 595-600
Category: Reviews

Summary

Approximately 4 % of female population suffers from diabetes. A permanent interaction between diabetes, its treatment and sex hormonal changes (childhood, puberty, reproduction, pregnancy, menopause) occurs in those women. This review article summarizes up to date published studies concerning reciprocal relationship between diabetes and sexual development in women.

Key words:
diabetes mellitus – gestation – hormonal contraceptive – hyperandrogenism – menopause – puberty – sex hormones

Zdroje

1. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 2002; 102(2): 151–166.

2. Hollingsworth DR. Alterations of maternal metabolism in normal and diabetic pregnancies: difference in insulin dependent, non-insulin dependent and gestational diabetes. Am J Obstet Gynecol 1983; 146(4): 417–429.

3. Godsland IF, Walton C, Felton C et al. Insulin resistance, secretion and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1992; 74(1): 64–70.

4. Wada T, Hori S, Sugiyama M et al. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2010; 298(4): E881-E888.

5. Woodward TS, Burghen GZ, Kitabachi AE et al. Glucose intolerance and insulin resistance in aplastic anaemia treated with oxymetholone. J Clin Endocrinol Metab 1981; 53(5): 905–908.

6. Hollingsworth DR. Alterations of maternal metabolism in normal and diabetic pregnancies: difference in insulin dependent, non-insulin dependent and gestational diabetes. Am J Obstet Gynecol 1983; 146(4): 417–429.

7. Polderman KH, Gooren LJG, Asscheman H et al. Induction of insulin resistance by androgens and estrogens. J. Clin Endocrinol Metab 1994; 79(1): 265–271.

8. Kumagai S, Holmang A, Bjornthorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 1993; 149(1): 91–97.

9. Tsibris JCM, Raynor LO, Buhi WC et al. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term. J Clin Endocrinol Metab 1980; 51(4): 711–717.

10. Moran C, Huerta L, Conway-Myers BA et al. Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovarian syndrome. Fertil Steril 2001; 75(3): 635–638.

11. Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT4 glucose transporters in adipocytes. Am J Physiol 1993; 264(2 Pt 1): E197-E202.

12. Silverstein JH, Rosenbloom AL. The journey to metabolic control in diabetes: many more miles to go. J Pediatr 2003; 143(6): 704–706.

13. Jovanovic L. Advances in diabetes for the millennium: diabetes in women. Med Gen Med 2004; 6(Suppl 3): 3.

14. Silbernagl S, Despopulos A. Atlas fyziologie člověka. Grada: Praha 1993: 262–263. ISBN 80–85623–79-X.

15. Escalante Pulido JM, Alpizar Salazar M. Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 1999; 30(1): 19–22.

16. Trout KK, Rickels MR, Schutta MH et al. Menstrual cycle effects on insulin sensitivity in women with type 1 diabetes: a pilot study. Diabetes Technol Ther 2007; 9(2): 176–182.

17. Goldner WS, Kraus VL, Sivitz WI et al. Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes. Diabetes Technol Ther 2004; 6(4): 473–480.

18. Cibula D, Henzl MR, Živný J et al. Základy gynekologické endokrinologie. Grada: Praha 2002: 21–26. ISBN 80–247–0236–3.

19. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002; 19(4): 322–326.

20. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 2001; 12(2): 78–82.

21. Greene MF. Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol 1999; 17(2): 127–136.

22. Chang AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology 2005; 146(5): 2445–2453.

23. Al-Agha R, Firth RG, Byrne M et al. Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995–2006). Ir J Med Sci 2012; 181(1): 105–109.

24. Dunne F, Brydon P, Smith K et al. Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990–2002. Diabet Med 2003; 20(9): 734–738.

25. Maso G, Piccoli M, Parolin S et al. Diabetes in pregnancy: timing and mode of delivery. Curr Diab Rep 2014; 14(7): 506.

26. Franconi F, Campesi I, Occhioni S et al. Sex-gender differences in diabetes vascular complications and treatment. Endocr Metab Immune Disord Drug Targets 2012; 12(2):179–196.

27. Salonia A, Lanzi R, Scavini M et al. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006; 29(2): 312–316.

28. Strotmeyer ES, Steenkiste AR, Foley jr. TP Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003; 26(4): 1016–1021.

29. Šnajderová M, Martínek J, Hořejší J et al. Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol 1999; 12(4): 209–214.

30. Schroeder B, Hertweck SP, Sanfilippo JS et al. Correlation between glycemic control and menstruation in diabetic adolescents. J Reprod Med 2000; 45(1): 1–5.

31. Deltsidou A, Lemonidou C, Zarikas V et al. Oligomenorrhoea in adolescents with type 1 diabetes mellitus: relationship to glycaemic control. Eur J Obstet Gynecol Reprod Biol 2010; 153(1): 62–66.

32. Codner E, Eyzaguirre FC, Iñiguez G et al. Chilean Group for the Study of Ovarian Function in Type 1 Diabetes. Ovulation rate in adolescents with type 1 diabetes mellitus. Fertil Steril 2011; 95(1): 197–202.

33. Yencilek F, Attar R, Erol B et al. Factors affecting sexual function in premenopausal age women with type 2 diabetes: a comprehensive study. Fertil Steril 2010; 94(5): 1840–1843.

34. Otunctemur A, Dursun M, Ozbek E et al. Impact of Metabolic Syndrome on Sexual Function in Pre- and Post-Menopausal Women. J Sex Marital Ther 2014; May 13: 1–10. [Epub ahead of print].

35. Solomon CG, Hu FB, Dunaif A et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286(19): 2421–2426.

36. Shim U, Oh JY, Lee HJ et al. Long menstrual cycle is associated with type 2 diabetes mellitus in korean women. Diabetes Metab J 2011; 35(4): 384–389.

37. Dishi M, Enquobahrie DA, Abetew DF et al. Age at menarche, menstrual cycle characteristics and risk of gestational diabetes. Diabetes Res Clin Pract 2011; 93(3): 437–442.

38. Ehrmann DA, Barnes RB, Rosenfield RL et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22(1): 141–146.

39. Plymate SR, Matej LA, Jones RE et al. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67(3): 460–464.

40. Salley KE, Wickham EP, Cheang KI et al. Glucose intolerance in polycystic ovary syndrome: a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007; 92(12): 4546–4556.

41. Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab 2010; 1(3): 117–128.

42. Bizzarri C, Benevento D, Ravà L et al. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index. Fertil Steril 2011; 96(6): 1497–1502.

43. Denoble AE, Hall KS, Xu X et al. Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical Conditions. Obstet Gynecol 2014; 123(6): 1213–1220.

44. Shawe J, Mulnier H, Nicholls P et al. Use of hormonal contraceptive methods by women with diabetes. Prim Care Diabetes. 2008; 2(4): 195–199.

45. Napoli A, Colatrella A, Botta R et al. Italian diabetic pregnancy study group (sid). contraception in diabetic women: an italian study. Diabetes Res Clin Pract 2005; 67(3): 267–272.

46. Lawrenson RA, Leydon GM, Williams TJ et al. Patterns of contraception in UK women with Type 1 diabetes mellitus: a GP database study. Diabet Med 1999; 16(5): 395–399.

47. Visser J, Snel M, Van Vliet HA. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2. Cochrane Database Syst Rev 2006; 4: CD003990.

48. Sadloňová J. Možnosti hormonální antikoncepce a substituce u diabetiček. Vnitř Lék 2009; 55(4): 375–383.